Jesper Borin

Comparative evaluation of dimeric and monomeric forms of ADAPT scaffold protein for targeting of HER2‐expressing tumours

S. Hober, V. Tolmachev, A. Orlova, 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Radionuclide therapy using ABD-fused ADAPT scaffold protein: Proof of Principle.

S. Hober, V. Tolmachev, A. Orlova, 2020, Biomaterials.

Phase I Study of 99mTc-ADAPT6, a Scaffold Protein–Based Probe for Visualization of HER2 Expression in Breast Cancer

S. Hober, V. Tolmachev, A. Orlova, 2020, The Journal of Nuclear Medicine.

Optimization of a calcium-dependent Protein A-derived domain for mild antibody purification

S. Hober, Julia Scheffel, Jesper Borin, 2019, mAbs.

The GRPR Antagonist [99mTc]Tc-maSSS-PEG2-RM26 towards Phase I Clinical Trial: Kit Preparation, Characterization and Toxicity

S. Hober, V. Tolmachev, A. Orlova, 2023, Diagnostics.